Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03600883
Brief Title: A Phase 1/2, Study Evaluating the Safety, Tolerability, PK, and Efficacy of AMG 510 in Subjects With Solid Tumors With a Specific KRAS Mutation.

First Submitted : June 26, 2018
First Submitted that Met QC Criteria : July 17, 2018
First Posted : July 26, 2018

Last Update Submitted that Met QC Criteria : October 9, 2019
Last Update Posted : October 10, 2019